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ABSTRACT 
FMF is an auto inflammatory disease mainly associated  with MEFV gene mutations. Until recently, 
the MEFV gene was considered to be responsible only for FMF. However, it is now known that it can 
also be associated with other clinical conditions. This study represents FMF-associated disease 
among our FMF clinic patients. 400 patients who had FMF based on the clinical and or MEFV gene 
study enrolled to study. Patients if needed were analyzed for the 12 most common MEFV mutations 
(P369S, F479L, M680I (G/C), M680I (G/A), I692del, M694V, M694I, K695R, V726A, A744S, 
R761H, E148Q) by a reverse hybridization assay. Any co-existed disease was confirmed by related 
subspecialist team. Among the patients Fifty two (13%) had associated disease.28 patients were male 
and 23 patients were under ten years old. Five patients had no MEFV mutations and overall, there 
were 82 MEFV gene mutations. The most common were M694V (30%), E148Q (22%), V726A 
(17%), M680I (1%) and M694I (0.07%) respectively. Rheumatologic disorders were the most 
common co-exist disease, then followed by GI and CNS disorder. Some rare disease such as TTP, 
Growth hormone deficiency, MS, ascitis and leiden factor V deficiency  have been  shown. This 
homozygote mutations (M694V-M694V) were associated with ascitis, orchitis and pericarditis. 
Associated disease in FMF usually presents in patients with MEFV gene mutations particularly with 
these five mutations M694V, E148Q, V726A, M680I, and M694I. Rheumatologic, gastrointestinal 
and CNS disorders are common co-existed disease. 
 
INTRODUCTION 
 FMF is an autosomal recessive disease mainly 
affecting ethnic groups living around the Mediterranean 
Sea: Jews, Armenians, Turks, Arabs, and Druse [1] with a 
prevalence ranging from 1/200 to 1/1000. [2] 
First manifestations have usually appeared by 4 
years of age and are characterized by recurrent, self-
limiting attacks of fever and polyserositis. Serositis 
presents as abdominal and chest pain. [3] 
Arthritis of the large joints and, less frequently, 
pericarditis and painful scrotal swelling or epididymitis can 
be found. Chronic destructive arthritis and severe 
prolonged myalgia or myositis due to vasculitis may occur 
[4, 5].Frequency of attacks is highly variable and 
asymptomatic periods that last a few years have been 
reported. Laboratory evaluation shows an acute phase 
response that can persist in asymptomatic periods [6, 7] 
Until 1998, the diagnosis of FMF was based on clinical 
grounds alone. The Tel Hashomer criteria form the basis of 
the clinical diagnosis.[8] 
In 1992, the gene responsible for FMF, MEFV, 
was found to reside on the short arm of chromosome 16. 
[9]Five years later, the MEFV gene locus was discovered 
that encode the protein named pyrin.[10] This protein 
probably has an important role in the down regulation of 
inflammation. 
In populations with a high FMF prevalence 
(Jewish, Armenian, Arab, Turkish) clinical criteria have a 
high speciﬁcity of 95–99% for the presence of genetically 
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conﬁrmed FMF, but sensitivity is much lower. In a recent 
study, FMF was genetically conﬁrmed in 60% of patients 
that fulﬁlled clinical criteria in Mediterranean origin, while 
was much lower in patients from other areas (10%) [11]. 
Patients with Mediterranean ancestry that fulfill 
FMF criteria but negative results for one or two MEFV 
mutations are usually considered as ‘clinical’ FMF. [12]. 
Until recently, the MEFV gene was considered to 
be responsible only for FMF. However, it is now known 
that it can also be associated with other clinical conditions. 
Additionally, various atypical presentations have been 
reported in which the clinical features were not typical of 
FMF but with positive results of MEFV gene mutations, 
and which, in many cases, resulted initially in 
misdiagnoses. [13] 
Coexistence of FMF with rheumatoid and 
autoimmune conditions like Sjögren’s syndrome. 
[14]seronegative spondyloarthropathy [15] Behcet’s 
disease [16] juvenile idiopathic arthritis [17, 18] 
rheumatoid arthritis(RA) [19] and inflammatory bowel 
disease (IBD)have been reported.  
It is also possible that mutations in the MEFV 
gene could be an additional susceptibility genetic factor in 
certain other disorders and it may participate in the 
manifestation of inflammatory disorders other than FMF. 
[13]  
This study represents associated and co-exist 
disease and atypical conditions with FMF patients in our 
FMF Clinic. (WWW.FMFIRAN.IR)  
 
METHODS 
400 patients who had FMF based on the clinical 
Tel – Hashomer criteria and or MEFV gene study enrolled 
to this study at FMF clinic in northwest of IRAN (Ardabil). 
Among them fifty two patients had associated disease that 
had been confirmed by related clinic and subspecialist. The 
patients were investigated for 12 known common FMF 
mutations by a reverse hybridization assay (FMF Strip 
Assay, Vienna lab, Vienna, Austria) according to the 
instructions provided by the manufacturer. About 10 ml of 
peripheral blood was used for extracting DNA by boiling –
based method. In a first step, exons 2, 3, 5 and 10 were 
amplified for each patient in a single, multiplex PCR, with 
primers supplied by the noted RDB kit. The thermocycling 
program of amplification was 35 cycles including (94c for 
15 sec,58c for 45 sec, and 72c for 45 sec) and a final 
extension at 72 c for 7 min. Agarose electrophoresis 
revealed the accuracy of amplification by detecting four 
amplified DNA fragments including 206, 236, 295 and 318 
bp. Biotinylated PCR products were selectively hybridized 
to a test strip presenting a parallel array of allele-specific 
oligonucleotide Probes. Thereby the twelve common 
mutations E148Q in exon 2, P369S in exon 3, F479L in 
exon 5 and M680I (G/C), M680I (G/A), I692del, M694V, 
M694I, K695R, V726A, A744S, R761H in exon 10 were 
determined. 
Statistical analysis was performed using SPSS V 
15.0, and P value 0.05 was accepted as statistically 
significant if needed. 
 
RESULTS 
Among the patients Fifty two (13%) had 
associated disease and atypical manifestations.28 patients 
were male and 23 patients were under ten years old. Five 
patients had no MEFV gene mutations. Table.1and 2 
There were 82 MEFV gene mutations. The most 
common were M694V (30%), E148Q (22%), V726A 
(17%), M680I (1%) and M694I (0.07%) respectively and 
other mutations (R761H, P369S, A744S, M694L, R202Q) 
were the rest. 
Rheumatologic disorders were the most common 
co-exist disease, (Arthritis, PFAPA, Vasculitis), followed 
by GI (Peptic ulcer, cholelithiasis) and CNS (migraine, 
seizure ,MS) disorder. Some rare disease such as TTP, 
Growth hormone deficiency, MS, ascitis and leiden factor 
V deficiency and retinitis pigmentosa have been shown. 
JIA had M680I- V726A mutations and in RA M694V- 
M680I or V726A mutations have been shown. This 
homozygote mutations (M694V-M694V) were associated 
with idiopathic ascitis, orchitis and pericarditis. There was 
not meaningful association between MEFV mutations and 
some specific disease. 
 
Table 1. Autoinflammatory, Inflammatory, Autoimmune and Vasculitis Disorders and conditions co-existed in our 
patients 
No. Age Sex MEFV Gen. Mutations Co-Exist  condition 
Auto inflammatory conditions 
1 7 M M680I-Wt (?) PFAPA 
2 18 M M694V- Wt (?) PFAPA 
3 6 F M694V- Wt (?) PFAPA 
4 5 F E148Q- Wt (?) PFAPA 
5 9 F V726A -Wt (?) PFAPA 
6 11 M R761H-M694I PFAPA 
Inflammatory joints disease 
7 14 F M680I- V726A JIA (Oligo A.) 
8 45 M M680I- M694V RA 
9 16 F M680I- V726A JIA (Oligo A.) 
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10 19 F M694V- V726A RA 
     
Organic-specific autoimmune disease 
11 7 F E148Q-V726A (IBD) UlCerative colitis 
12 38 M M680I-Wt (?) (IBD) Crohn Disease 
13 10 M Wt (?)-Wt (?) Alopecia totalis 
14 37 F Wt (?)-Wt (?) Multiple Sclerosis(MS) 
15 11 M E148Q-P369S Celiac 
16 21 M R761H-V726A 
TTP (Thrombotic Thrombocytopenic 
Purpura) 
Systemic Vasculitis 
17 5 F E148Q- Wt (?) (IgAV) Henoch–Schönlein purpura 
18 7 F E148Q-V726A Behcet Disease 
19 29 M M694V-  E148Q Protracted febrile myalgia syndrome (PFMS) 
20 20 M M680I-V726A (IgAV) Henoch–Schönlein purpura 
Non-clarified associated serositis 
21 12 M M694V- V726A Pleuritis (Recurent  Idiopathic /FMF related) 
22 13 M M694V- M694V 
Pericarditis (Recurent Idiopathic/FMF 
related ) 
23 49 F M694V-M694V Ascites (Idiopathic /FMF related  ) 
24 46 F M694V- M694V Ascites (Idiopathic /FMF related) 
25 23 M M694V-M694V Orchitis(Idiopathic recurrent /FMF related) 
 
Table 2. Non-inflammatory conditions found in our patients 
No. age sex MEFV Gen. Mutations Co-Exist  conditions 
Hematologic, Hormonal ,Metabolic conditions 
26 12 F E148Q- Wt (?) Thalassemia 
27 8 F E148Q-M694V Thalassemia 
28 43 M Wt (?)-Wt (?) Hyperlipidemia 
29 45 F M694V- Wt (?) Infertility(Idiopathic) 
30 9 F M694V-M680I Growth hormone deficiency 
31 45 M M680I- M694V LIDEN Factor Deficiency 
32 21 M R761H-V726A Pancytopenia 
33 41 F E148Q- V726A Hypothyroidism(Idiopathic) 
34 25 F M694L-R202Q Retinitis pigmentosa 
Common non inflammatory disease/Conditions 
35 22 F E148Q- P369S Peptic Ulcer Disease 
36 8 F E148Q-M694V Peptic Ulcer Disease 
37 41 M Wt (?)- Wt (?) Peptic Ulcer Disease 
38 13 M Wt (?)- Wt (?) Peptic Ulcer Disease 
39 47 F M694I- V726A Peptic Ulcer Disease 
40 10 F E148Q- P369S Cholelithiasis 
41 9 M E148Q- P369S Cholelithiasis 
42 11 M M694I-  M694I Cholelithiasis 
43 7 M M680I- V726A Cholelithiasis 
44 12 F E148Q- Wt (?) Migraine 
45 8 F A744S- Wt (?) Migraine 
46 11 M E148Q- Wt (?) Migraine 
47 15 F M694V- Wt (?) Seizure(idiopathic) 
48 11 M R761H-M694I seizure(idiopathic) 
49 8 M M694V- V726A Seizure(idiopathic) 
50 5 M E148Q-A744S Vesicoureteral  Reflux 
51 5 M E148Q-A744S Gastroesophageal Reflux 
52 12 F E148Q- Wt (?) Congenital Cardiac Anomaly 
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DISCUSSION 
Vasculitides are found in FMF patients at a higher 
incidence than in the unaffected population. [20]Three 
forms of systemic vasculitis have been described to occur 
in FMF”: polyarteritis nodosa (PAN), microscopic 
polyangiitis and IgA vasculitis (IgAV) formerly named  
Henoch Schonlein purpura (HSP). [21, 22]  
In our series we had two cases of (IgAV)  (0.5%) 
with MEFV mutations in both of them; while HSP have 
been reported in3% even to 11% of FMF patients [23] 
Occult FMF cases were identified in a series of children 
with (IgAV)  from Israel. The (IgAV) incidence in the 
general population is 20/100,000 aged < 17 years (24), and 
in one study in FMF patients varies from 2.6% to 3.6 %[ 
25]  
PAN also occurs more commonly in patients with 
FMF with a younger age of onset. [26] We could not detect 
any case of PAN among the patients. The prevalence of 
PAN in FMF patients is about 1% (27) Hypertension and 
nephritis are more likely to occur in PAN than in FMF-
PAN patients. [28] Data from evolutionary studies also 
gives the impression that PAN is less severe in FMF 
patients. [29]As in patients with PAN-FMF, the prevalence 
of antistreptolysin O antibody elevation is high [30].Data 
are insufficient to determine whether these disorders are 
more common in FMF patients than in the general 
population. [31]. 
We had two cases of JIA with Oligo- type and 
same mutations (M680I- V726A) in both and two cases of 
RA which showed combined heterozygote mutations. 
Recurrent monoarthritis can be the sole manifestation of 
FMF; in such cases, the true diagnosis may not be 
established for some time. Lidar et al. conducted a study to 
clinically and genetically characterize patients with FMF in 
whom arthritis constituted the only manifestation .The 
authors concluded those FMF groups were febrile with 
short duration arthritis, positive family history of FMF and 
mutation analysis, and good response to colchicines. [32]. 
Ayaz et al. screened 35 children with the diagnosis of 
systemic onset juvenile idiopathic arthritis (SoJIA) for 12 
MEFV mutations. The overall mutation frequency of 
patients was 14.28 %,[ 33] 
In our study there was a patient with recurrent 
febrile chest pain as the only manifestation of FMF and 
combined MEFV mutation (M694V- V726A). Pleuritis can 
rarely present as the sole manifestation of FMF. As a rule 
in patients with paroxysmal febrile attacks and chest pain, 
especially if they originate from the eastern Mediterranean 
area, FMF should be considered [13] 
Recurrent pericarditis, though rare, can present as 
the single manifestation of FMF. Okutur et al. described a 
25-year-old Turkish woman who presented with recurrent 
pericarditis of no obvious cause [34].In our series there 
was one case with same problem and M694V- M694V 
mutation analysis. 
In our series there was not any especial skin 
disease except a case of alopecia without MEFV gene 
mutation, but recurrent urticaria has been reported as a rare 
manifestation of FMF. Alonso et al. described a patient 
referred for recurrent urticaria and final diagnosis of FMF 
[35]. 
Neurological involvement is rare but has been 
reported and varies from headache to aseptic meningitis. 
Meningitis can occur rarely in FMF. In each of the 
reported cases, the patients’ attacks of recurrent aseptic 
meningitis resolved after treatment with colchicine. [36, 
37, 38, and 39]  
FMF-associated central nervous system (CNS) 
involvement includes demyelinating lesions, stroke, and 
posterior reversible leukoencephalopathy syndrome 
(PRES). Approximately 70% of patients had the 
homozygote M694V mutation. Neurologic involvement is 
rare but serious in FMF. [40]  
This study represents three cases of migraine and 
three cases of seizure disorder with at least one MEFV 
gene mutation in.  
We had one MS patient who did not show MEFV 
gene mutations. More recent study found that MS patients 
with MEFV mutations seem to develop a more progressive 
disease and on the other hand MEFV mutations may 
increase the risk of MS development. [41, 42] 
In this work, there is a Behcet child with E148Q-
V726A mutations analysis. An increased frequency of 
MEFV mutations has been found in individuals with 
Behcet disease. FMF carriers with Behcet disease have 
been found to have an increased risk for venous 
thrombosis. [43] Both FMF and Behcet disease are 
observed all around the Mediterranean basin, but Behcet 
disease clusters along the ancient Silk Road [44] 
From different studies [45, 46, 47, and 48] BD 
patients have a higher frequency of MEFV mutations than 
controls, and that this high prevalence provides a further 
argument to support the proposal that MEFV mutations 
may participate in the manifestation of inflammatory 
disorders other than FMF. [48]. 
This study contains two cases of IBD with 
E148Q-V726A mutations in Ulcerative Colitis (UC) and 
M680I-Wt (?) in Crohn disease (CD). Some studies have 
found an increased frequency of MEFV mutations in 
patients with UC, and this may suggest a possible 
modifying effect of MEFV in the disease process. 
[20]Other studies have found that CD seems to be more 
prevalent in FMF and presents later than in patients 
without FMF. [49, 50]MEFV gene mutations may act as 
modifiers, affecting the expression of IBD. [13] 
Although there was not any cases in our patients, 
Streptococcus associated diseases with the presence of 
high levels of antistreptolysin O (ASO) antibodies and 
streptococcus-associated diseases, such as acute post-
streptococcal glomerulonephritis and acute rheumatoid 
fever have been reported in patients with FMF. 
[51]Patients with FMF certainly have an exaggerated 
response to streptococcal antigens and may be more prone 
to the late complications of streptococcal infection. [20] 
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In this work there were four cases of peptic ulcer 
disease (PUD) and four patients with cholelithiasis (CL), 
which in most of PUD and all CL there was combined 
heterozygote mutations.(table. 2) 
Here we represent one patient with celiac disease 
and FMF with E148Q-P369S mutations. FMF and celiac 
disease (CD) may share genetic and epigenetic factors as 
well as certain clinical features [52] however; association 
between FMF and CD remains controversial. 
Two sisters with idiopathic ascitis and FMF were 
in this study with similar MEFV gene mutations, M694V-
M694V. A female patient with FMF who developed 
chronic ascites has been reported recently by Ureten et al. 
She was a compound heterozygote for the mutations 
M694Vand M680I, and after dose adjustment of 
colchicine, the amount of ascites decreased [53] 
There was one patient with recurrent orchitis and 
M694V-M694V mutations, although acute scrotum is 
rarely seen as a complication of FMF [54]. 
Patients with growth hormone deficiency, TTP, 
Leiden Factor deficiency and retinitis pigmentosa were 
additional and probably unreported association in this 
study. We have discussed about the MEFV gene and 
PFAPA in distinct article(in press); however, here we 
report six FMF patients with co-existed PFAPA. In these 
entire patients MEFV gene mutations are positive and one 
of them had compound heterozygote mutations (R761H-
M694I).In half of these patients PFAPA presented firstly, 
and in the others FMF developed earlier than PFAPA. 
Initially we thought these patients are colchicine resistant 
FMF, but more work up and closed observation with good 
response to single dose prednisolon during attacks revealed 
their co-existed PFAPA. On the basis of this finding 
particularly in young patients with colchicine resistant 
FMF, we recommend co-existed PFAPA as a possible 
condition.  
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